Paula M. Vertino, Ph.D.

Contact Information

Administrative: (585) 275-4726

Professor - Department of Biomedical Genetics (SMD)
Wilmot Distinguished Professorship in Cancer Genomics - Cancer Center
Professor - Cancer Center - Joint
Professor - Department of Pathology and Laboratory Medicine (SMD) - Joint

Dr. Vertino's research interests are focused on the areas of cancer epigenetics and novel mechanisms of gene silencing in cancer.

3/17/2021
Barwick BG, Gupta VA, Matulis SM, Patton JC, Powell DR, Gu Y, Jaye DL, Conneely KN, Lin Y, Hofmeister CC, Nooka AK, Keats JJ, Lonial S, Vertino PM, Boise LH. "Chromatin accessibility identifies regulatory elements predictive of gene expression and disease outcome in multiple myeloma." Clinical cancer research : an official journal of the American Association for Cancer Research.. 2021 Mar 17; Epub 2021 Mar 17.

3/17/2021
Zhang B, Li Y, Wu Q, Xie L, Barwick B, Fu C, Li X, Wu D, Xia S, Chen J, Qian WP, Yang L, Osunkoya AO, Boise L, Vertino PM, Zhao Y, Li M, Chen HR, Kowalski J, Kucuk O, Zhou W, Dong JT. "Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer." Nature communications.. 2021 Mar 17; 12(1):1714. Epub 2021 Mar 17.

2021
Miyauchi T, Takahashi M, Mitsuzuka K, Saiki Y, Okubo T, Vertino PM, Goto A, Arai Y, Horii A, Fukushige S. "Aberrant Hypermethylation-Mediated Suppression of PYCARD Is Extremely Frequent in Prostate Cancer with Gleason Score???7." Disease markers.. 2021 2021:8858905. Epub 2021 Feb 04.